Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TXO | HPK |
|---|---|---|
| Price | $13.93 | $8.52 |
| Change today | ▼ 0.21% | ▲ 3.65% |
| Market cap | $772.37M | $1.08B |
| Return, 3 months | +9.3% | +21.7% |
| Return, year to date | +41.5% | +79.7% |
| Return, 1 year | +9.0% | +21.6% |
| P/E (TTM) | -19.1 | -12.5 |
| P/B | 1.2 | 0.7 |
| P/E percentile vs own 5y | 11th | 0th |
| Dividend yield | 10.48% | 0.94% |
| Revenue growth (YoY, latest qtr) | +67.9% | +25.8% |
| Net profit growth (YoY) | +45,115.6% | +214.3% |
| Gross margin | 27.1% | 21.5% |
| Operating margin | -0.2% | 15.7% |
| Net margin | -9.2% | -9.8% |
| Return on equity | -5.3% | -5.3% |
| Analyst target vs. price | +40.0% | +17.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 42 | 59 |
| 30-day volatility | 26.4% | 49.3% |
| Max drawdown, 1 year | -28.1% | -46.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
